Aydın, T.İ.; Öztürk, G.; Akkuş, A.F.; Taştekin, E.; Topaloğlu, S.; Erdoğan, B.; Küçükarda, A.; Hacioğlu, M.B.
Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer. Medicina 2026, 62, 1011.
https://doi.org/10.3390/medicina62061011
AMA Style
Aydın Tİ, Öztürk G, Akkuş AF, Taştekin E, Topaloğlu S, Erdoğan B, Küçükarda A, Hacioğlu MB.
Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer. Medicina. 2026; 62(6):1011.
https://doi.org/10.3390/medicina62061011
Chicago/Turabian Style
Aydın, Tayyip İlker, Gökhan Öztürk, Aysun Fatma Akkuş, Ebru Taştekin, Sernaz Topaloğlu, Bülent Erdoğan, Ahmet Küçükarda, and Muhammet Bekir Hacioğlu.
2026. "Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer" Medicina 62, no. 6: 1011.
https://doi.org/10.3390/medicina62061011
APA Style
Aydın, T. İ., Öztürk, G., Akkuş, A. F., Taştekin, E., Topaloğlu, S., Erdoğan, B., Küçükarda, A., & Hacioğlu, M. B.
(2026). Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer. Medicina, 62(6), 1011.
https://doi.org/10.3390/medicina62061011
